II. Risk Factors
- Risk increases with total daily doses >0.7 mg/day (esp. >1.2 mg/day, and prolonged use)
- Significant withdrawal has occurred at doses of 0.1 mg daily after only 1 week
- Concurrent Beta Blocker use
- Consider tapering off Beta Blocker several days before stopping Clonidine
- Exaggerated hypertensive response related to unopposed Catecholamine-induced Vasoconstriction
III. Findings: Peak 2-4 days after Clonidine cessation
- Rebound Hypertension
- Diaphoresis
- Tachycardia (and Palpitations)
- Anxiety
- Insomnia
- Nausea and Vomiting
IV. Labs
- Urine Catecholamine increase (also seen with Pheochromocytoma)
- Serum Troponin
- Serum Creatinine
V. Diagnostics: Consider based on findings
VI. Management
- Option 1
- Prazosin 10 mg orally twice daily AND
- Atenolol 50 mg orally daily AND
- Chlordiazepoxide (Librium) 10 mg orally twice daily
- Option 2
- Propranolol AND
- Phentolamine AND
- Labetalol
- Option 3
- Vasodilator (e.g. Hydralazine, Nitroprusside) AND
- Beta Blockers
VII. Prevention
- Slowly taper dose every 3 to 7 days to prevent rebound Hypertension
- Taper Beta Blockers off several days before discontinuing Clonidine
- Continue in Clonidine in the perioperative period
VIII. Complications
IX. References
- Mishler and Lovecchio (2017) Crit Dec Emerg Med 31(11): 15-20
- Bailey (1976) Br Med J 1(6015):942-3 [PubMed]